Smarty, maybe you could get your source to issue a "fluff" piece on what all the current disease application identifiers are for Cymerus (including all the “internal planning” ones). Better still, issue them along with the “Corporation Presentations” associated with each.
This may instil some confidence in the long-term suffering shareholders that some sort of progress is being made toward commercialising something.
Because as far as I am aware, CYP-003 has not been mentioned anywhere!
So now we know of CYP-001, CYP-002, CYP-003 and CYP-004.
Be nice to see CYP-005, CYP-006,… CYP-00x announcements over the coming months.
Going forward..., page-1412
-
- There are more pages in this discussion • 719 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.005(2.00%) |
Mkt cap ! $45.80M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 25.5¢ | 25.5¢ | $313 | 1.229K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 22209 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 36715 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |